Back to
VANGUARD GROUP INC
CUE
6 quarters
Position history for
VANGUARD GROUP INC's holdings in CUE BIOPHARMA INC
As of its last 13F, for Q4 2025, Vanguard Group held 3,014,034 shares of CUE (Cue Biopharma), worth $919,280. It reduced the position by 25,288 shares (-0.8%) from Q3 2025. Vanguard Group held CUE from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.
Current Value
$919,280
Current Shares
3M
Total Value Change
-$618,506
Total Shares Change
+982,613
Quarter-by-Quarter History